GGT: An Accurate, Inexpensive Predictor of Cardiometabolic Risk

Gamma glutamyl transferase (GGT) is a hepatic enzyme that indicates levels of oxidative stress in the liver. A large body of research suggests that it can also predict onset of insulin resistance, type 2 diabetes, and cardiovascular disease. At under $10 per test, it could be a very valuable asset in clinical practice.

The Content you are trying to see is available only for members of our site. If you already have a Membership you need to log in to see it. Please follow this link if you want to register.
 
Subscribe to Holistic Primary Care